Article

In vitro analysis of iron chelating activity of flavonoids.

Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Hradec Králové, Czech Republic.
Journal of inorganic biochemistry (impact factor: 3.25). 02/2011; 105(5):693-701. DOI:10.1016/j.jinorgbio.2011.02.003 pp.693-701
Source: PubMed

ABSTRACT Flavonoids have been demonstrated to possess miscellaneous health benefits which are, at least partly, associated with iron chelation. In this in vitro study, 26 flavonoids from different subclasses were analyzed for their iron chelating activity and stability of the formed complexes in four patho/physiologically relevant pH conditions (4.5, 5.5, 6.8, and 7.5) and compared with clinically used iron chelator deferoxamine. The study demonstrated that the most effective iron binding site of flavonoids represents 6,7-dihydroxy structure. This site is incorporated in baicalein structure which formed, similarly to deferoxamine, the complexes with iron in the stoichiometry 1:1 and was not inferior in all tested pH to deferoxamine. The 3-hydroxy-4-keto conformation together with 2,3-double bond and the catecholic B ring were associated with a substantial iron chelation although the latter did not play an essential role at more acidic conditions. In agreement, quercetin and myricetin possessing all three structural requirements were similarly active to baicalein or deferoxamine at the neutral conditions, but were clearly less active in lower pH. The 5-hydroxy-4-keto site was less efficient and the complexes of iron in this site were not stable at the acidic conditions. Isolated keto, hydroxyl, methoxyl groups or an ortho methoxy-hydroxy groups were not associated with iron chelation at all.

0 0
 · 
0 Bookmarks
 · 
47 Views
  • Source
    Article: Involvement of iron in biofilm formation by Staphylococcus aureus.
    [show abstract] [hide abstract]
    ABSTRACT: Staphylococcus aureus is a human pathogen that forms biofilm on catheters and medical implants. The authors' earlier study established that 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose (PGG) inhibits biofilm formation by S. aureus by preventing the initial attachment of the cells to a solid surface and reducing the production of polysaccharide intercellular adhesin (PIA). Our cDNA microarray and MALDI-TOF mass spectrometric studies demonstrate that PGG treatment causes the expression of genes and proteins that are normally expressed under iron-limiting conditions. A chemical assay using ferrozine verifies that PGG is a strong iron chelator that depletes iron from the culture medium. This study finds that adding FeSO(4) to a medium that contains PGG restores the biofilm formation and the production of PIA by S. aureus SA113. The requirement of iron for biofilm formation by S. aureus SA113 can also be verified using a semi-defined medium, BM, that contains an iron chelating agent, 2, 2'-dipyridyl (2-DP). Similar to the effect of PGG, the addition of 2-DP to BM medium inhibits biofilm formation and adding FeSO(4) to BM medium that contains 2-DP restores biofilm formation. This study reveals an important mechanism of biofilm formation by S. aureus SA113.
    PLoS ONE 01/2012; 7(3):e34388. · 4.09 Impact Factor

Keywords

2,3-double bond
 
26 flavonoids
 
3-hydroxy-4-keto conformation
 
5-hydroxy-4-keto site
 
acidic conditions
 
baicalein structure
 
catecholic B ring
 
effective iron binding site
 
essential role
 
Flavonoids
 
formed complexes
 
iron chelating activity
 
iron chelation
 
iron chelator deferoxamine
 
methoxyl groups
 
miscellaneous health benefits
 
neutral conditions
 
patho/physiologically relevant pH conditions
 
substantial iron chelation
 
three structural requirements